Attached files

file filename
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR33.htm
EX-32 - EXHIBIT 32.1 - IRIS BIOTECHNOLOGIES INCirsb11132012exh321.htm
EX-31 - EXHIBIT 31.1 - IRIS BIOTECHNOLOGIES INCirsb11132012exh311.htm
EXCEL - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR7.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR3.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR4.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR8.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR5.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR1.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR9.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR32.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR25.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR23.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR27.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR10.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR19.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR34.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR16.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR14.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR18.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR28.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR17.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR11.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR12.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR15.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR26.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR29.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR24.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR30.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR31.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR22.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR13.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR21.htm
10-Q - FORM 10-Q - IRIS BIOTECHNOLOGIES INCirsb11082012form10q.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR6.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR20.htm
v2.4.0.6
CONDENSED BALANCE SHEETS (Unaudited) (USD $)
Sep. 30, 2012
Dec. 31, 2011
Current assets:    
Cash $ 6,040 $ 43,729
Total current assets 6,040 43,729
Property, plant and equipment, net of accumulated depreciation of $227,589 and $215,844 as of September 30, 2012 and December 31, 2011, respectively 11,211 22,956
Total assets 17,251 66,685
Current liabilities:    
Accounts payable 44,363 34,802
Total current liabilities 44,363 34,802
Long term debt:    
Convertible notes payable 45,000   
Total liabilities 89,363 34,802
STOCKHOLDERS' EQUITY (DEFICIT)    
Preferred stock, no par; 5,000,000 shares authorized; no shares issued and outstanding as of September 30, 2012 and December 31, 2011      
Common stock, no par; 20,000,000 shares authorized; 12,872,073 and 12,605,573 shares issued and outstanding as of September 30, 2012 and December 31, 2011, respectively $ 6,672,704 $ 6,477,603
Additional paid in capital 2,389,780 2,288,376
Common stock subscription 30,000   
Common stock subscription receivable (128,375) (128,375)
Deficit accumulated during development stage (9,036,221) (8,605,721)
Total stockholders' (deficit) equity (72,112) 31,883
Total liabilities and stockholders' (deficit) equity $ 17,251 $ 66,685